Dark

RGC
Regencell Bioscience Holdings Limited
stock NASDAQ

At Close

Jun 23, 2025 3:59:48 PM EDT

23.47USD-38.253%(-14.54)1,829,776

23.10Bid 30.00Ask 6.90Spread

Pre-market

Jun 23, 2025 9:28:30 AM EDT

30.65USD-19.363%(-7.36)37,048

After-hours

Jun 23, 2025 4:43:30 PM EDT

22.76USD-3.025%(-0.71)8,037

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

11.64B

Headquarters

TN, USA

Industry

Drug Manufacturers-Specialty & Generic

Last Split

Jun 16, 202538for1

RDI MCS CNK AMC

RGC Stats

Avg. Vol. 10 Day

1,904,902

Avg. Vol. 30 Day

2,013,700

Employees

26,000

Market Cap

11,635,324,005

Shares Out.

494,488,908

On/Off Exchange

60%/40%

6 Month Beta

-0.54

1 Year Beta

-0.48

2 Year Beta

-0.39

3 Year Beta

-0.18

52 Week Low

0.08

52 Week High

83.60

SMA50

12.58

SMA200

3.31

1 Week

-60.78%

1 Month

+59.67%

3 Month

+2,080.93%

6 Month

+18,649.00%

1 Year

+26,015.43%

2 Year

+3,456.53%

5 Year

+8,416.11%

Profile

we are an early-stage bioscience company that focuses on research, development and commercialization of tcm for the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder ("adhd"), autism spectrum disorder ("asd") in infectious diseases such as covid-19. our goal is to improve the lives of adhd, asd and covid patients, their families and caregivers and become a market leader for the best tcm treatment globally.

RGC Stock Summary

Regencell Bioscience Holdings Limited (NASDAQ:RGC) stock price today is $23.47, and today's volume is 1,829,776. RGC is down -38.253% today. The 30 day average volume is 2,013,700. RGC market cap is 11.64B with 494,488,908 shares outstanding.